Benzinga’s Top Ratings Upgrades, Downgrades For September 29, 2023
Upgrades For Nike Inc (NYSE:NKE), Williams Trading upgraded the previous rating of Sell to Hold. Nike earned $0.94…
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market trading.
Nike, OPKO Health And Other Big Stocks Moving Higher In Friday’s Pre-Market Session
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session.
Brooge Energy Limited (NASDAQ: BROG) shares surged 23% to $6.64 in pre-market trading after gaining 7% on Thursday.
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Analyst Expectations for Editas Medicine’s Future
Over the past 3 months, 5 analysts have published their opinion on Editas Medicine (NASDAQ:EDIT) stock. These analysts…
Expert Ratings for Editas Medicine
Analysts have provided the following ratings for Editas Medicine (NASDAQ:EDIT) within the last quarter: Bullish Somewhat Bullish Indifferent…
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell
• Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
What 6 Analyst Ratings Have To Say About Editas Medicine
Editas Medicine (NASDAQ:EDIT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…